Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VESIcare® safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tabletsInitial U.S. Approval: 2004
Medication labelWhy this: Advisory · dailymed-prescription
VESIcare® is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
- generic_name
- solifenacin succinate
- product_names
- solifenacin succinate
- ndc
- 68151-5406, 51248-150, 68151-5406-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en